The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial.
 
Jaleh Fallah
No Relationships to Disclose
 
Rekha T. Chaudhary
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
Honoraria - Novocure
 
Lisa R. Rogers
Speakers' Bureau - Novocure
 
Wei Wei
No Relationships to Disclose
 
Cathy J. Brewer
No Relationships to Disclose
 
David M. Peereboom
Consulting or Advisory Role - Orbus Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mylan (Inst); Neonc Technologies (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Stemline Therapeutics
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Flatiron Health; FORMA Therapeutics; Kadmon; Karyopharm Therapeutics; Tocagen; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)